MAP Kinase Phosphatase-1 Protects Against Inflammatory Bone Loss

Overview

Journal J Dent Res

Specialty Dentistry

Date 2009 Oct 30

PMID 19864641

Citations 40

Authors

R Sartori

F Li

K L Kirkwood

Affiliations

Soon will be listed here.

Abstract

The mitogen-activated protein (MAP) kinase phosphatase (MKP) family plays an important function in regulating the pro-inflammatory cytokines by deactivating MAP kinases. MKP-1 is essential for the dephosphorylation of p38 MAP kinase that regulates expression of IL-6, TNF-alpha, and IL-1 beta. We hypothesized that MKP-1 regulates inflammatory bone loss in experimental periodontitis. Wild-type and Mkp-1(-/-) mice received A. actinomycetemcomitans LPS injection in the palatal region or PBS control 3 times/wk for 30 days. Mice were killed, and maxillae were assessed by microcomputed tomography, histological analysis, and TRAP staining for measurement of bone loss, extent of inflammation, and degree of osteoclastogenesis. Results indicated that, in LPS-injected Mkp-1(-/-) mice, significantly greater bone loss occurred with more inflammatory infiltrate and a significant increase in osteoclastogenesis compared with Mkp-1(-/-) control sites or either wild-type group. Analysis of these data indicates that MKP-1 plays a key role in the regulation of inflammatory bone loss.

Citing Articles

Murine Models in Oral Research: A Narrative Review of Experimental Approaches and Cardiovascular Implications.

Elhaieg A, Farag A, Mandour A, Hirose M, Elfadadny A, Tanaka R Biology (Basel). 2025; 14(2).

PMID: 40001895 PMC: 11851954. DOI: 10.3390/biology14020127.

GPR40 deficiency worsens metabolic syndrome-associated periodontitis in mice.

Li Y, Lu Z, Kirkwood C, Kirkwood K, Wank S, Li A J Periodontal Res. 2023; 58(3):575-587.

PMID: 36807310 PMC: 10182248. DOI: 10.1111/jre.13107.

The Oral-Gut Axis: Periodontal Diseases and Gastrointestinal Disorders.

Lam G, Albarrak H, McColl C, Pizarro A, Sanaka H, Gomez-Nguyen A Inflamm Bowel Dis. 2022; 29(7):1153-1164.

PMID: 36527679 PMC: 10320234. DOI: 10.1093/ibd/izac241.

Temporal changes of periodontal tissue pathology in a periodontitis animal model.

Yoon H, Jung B, Yoo K, Lee J, Um H, Chang B J Periodontal Implant Sci. 2022; 53(4):248-258.

PMID: 36468486 PMC: 10465809. DOI: 10.5051/jpis.2203420171.

Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes.

Gado M, Baschant U, Hofbauer L, Henneicke H Front Endocrinol (Lausanne). 2022; 13:835720.

PMID: 35432217 PMC: 9008133. DOI: 10.3389/fendo.2022.835720.

References

Delima A, Oates T, Assuma R, Schwartz Z, Cochran D, Amar S . Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. J Clin Periodontol. 2001; 28(3):233-40. DOI: 10.1034/j.1600-051x.2001.028003233.x. View

Chen P, Li J, Barnes J, Kokkonen G, Lee J, Liu Y . Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J Immunol. 2002; 169(11):6408-16. DOI: 10.4049/jimmunol.169.11.6408. View

Delima A, Karatzas S, Amar S, Graves D . Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists. J Infect Dis. 2002; 186(4):511-6. DOI: 10.1086/341778. View

Schumann R, Pfeil D, Lamping N, Kirschning C, Scherzinger G, Schlag P . Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14. Blood. 1996; 87(7):2805-14. View

Keyse S . Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol. 2000; 12(2):186-92. DOI: 10.1016/s0955-0674(99)00075-7. View

Graves D . The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin Infect Dis. 1999; 28(3):482-90. DOI: 10.1086/515178. View

Salojin K, Owusu I, Millerchip K, Potter M, Platt K, Oravecz T . Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol. 2006; 176(3):1899-907. DOI: 10.4049/jimmunol.176.3.1899. View

Nimah M, Zhao B, Denenberg A, Bueno O, Molkentin J, Wong H . Contribution of MKP-1 regulation of p38 to endotoxin tolerance. Shock. 2004; 23(1):80-7. DOI: 10.1097/01.shk.0000145206.28812.60. View

Rogers J, Li F, Coatney D, Otremba J, Kriegl J, Protter T . A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model. J Periodontol. 2007; 78(10):1992-8. DOI: 10.1902/jop.2007.070101. View

10.

Kikuchi T, Yoshikai Y, Miyoshi J, Katsuki M, Musikacharoen T, Mitani A . Cot/Tpl2 is essential for RANKL induction by lipid A in osteoblasts. J Dent Res. 2003; 82(7):546-50. DOI: 10.1177/154405910308200712. View

11.

Shepherd E, Zhao Q, Welty S, Hansen T, Smith C, Liu Y . The function of mitogen-activated protein kinase phosphatase-1 in peptidoglycan-stimulated macrophages. J Biol Chem. 2004; 279(52):54023-31. DOI: 10.1074/jbc.M408444200. View

12.

Wang X, Nelin L, Kuhlman J, Meng X, Welty S, Liu Y . The role of MAP kinase phosphatase-1 in the protective mechanism of dexamethasone against endotoxemia. Life Sci. 2008; 83(19-20):671-80. PMC: 2600599. DOI: 10.1016/j.lfs.2008.09.003. View

13.

Chi H, Barry S, Roth R, Wu J, Jones E, Bennett A . Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci U S A. 2006; 103(7):2274-9. PMC: 1413743. DOI: 10.1073/pnas.0510965103. View

14.

Mori Y, Yoshimura A, Ukai T, Lien E, Espevik T, Hara Y . Immunohistochemical localization of Toll-like receptors 2 and 4 in gingival tissue from patients with periodontitis. Oral Microbiol Immunol. 2003; 18(1):54-8. DOI: 10.1034/j.1399-302x.2003.180109.x. View

15.

Kirkwood K, Li F, Rogers J, Otremba J, Coatney D, Kreider J . A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss. J Pharmacol Exp Ther. 2006; 320(1):56-63. DOI: 10.1124/jpet.106.112466. View

16.

Assuma R, Oates T, Cochran D, Amar S, Graves D . IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol. 1998; 160(1):403-9. View

17.

An H, Yu Y, Zhang M, Xu H, Qi R, Yan X . Involvement of ERK, p38 and NF-kappaB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology. 2002; 106(1):38-45. PMC: 1782697. DOI: 10.1046/j.1365-2567.2002.01401.x. View

18.

Zhao Q, Shepherd E, Manson M, Nelin L, Sorokin A, Liu Y . The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J Biol Chem. 2004; 280(9):8101-8. DOI: 10.1074/jbc.M411760200. View

19.

Rogers J, Li F, Coatney D, Rossa C, Bronson P, Krieder J . Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis. J Periodontol. 2007; 78(3):550-8. PMC: 2683373. DOI: 10.1902/jop.2007.060321. View

20.

Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H . Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun. 2000; 275(3):768-75. DOI: 10.1006/bbrc.2000.3379. View